Frenquelli, M.
Caridi, N.
Antonini, E.
Storti, F.
Viganò, V.
Gaviraghi, M. http://orcid.org/0000-0003-2791-3638
Occhionorelli, M.
Bianchessi, S.
Bongiovanni, L.
Spinelli, A.
Marcatti, M.
Belloni, D.
Ferrero, E.
Karki, S.
Brambilla, P.
Martinelli-Boneschi, F.
Colla, S.
Ponzoni, M.
DePinho, R. A.
Tonon, G. http://orcid.org/0000-0003-2973-5038
Funding for this research was provided by:
Fondazione Cariplo
Associazione Italiana per la Ricerca sul Cancro (9965)
Multiple Myeloma Research Foundation
Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute (GR-2011-02351686)
Article History
Received: 7 November 2018
Revised: 8 April 2019
Accepted: 10 April 2019
First Online: 31 May 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest. Although not directly impacting this study, R.A.D. is a co-founder, advisor and director of Tvardi Therapeutics.